CELL & GENE: Looking Beyond Alpha-Beta Cells for Cell Therapies
Peter Bak, PhD and Kyle O’Neil
In part one of a two-part series, published this week in Cell & Gene, Back Bay Life Science Advisors explores the evolution of cell therapies of the innate immune system (such as γδ T and NK cells) to understand why these approaches offer great hope for oncology and the potential value they may offer second-generation cell therapy companies.
Read part 1 of Back Bay’s article in Cell & Gene
In part two, Back Bay takes a deep dive into the commercial impact of these new therapies.